Phage display selection on whole cells yields a small peptide specific for HCV receptor human CD81

被引:28
作者
Cao, J
Zhao, P
Miao, XH
Zhao, LJ
Xue, LJ
Qi, ZT
机构
[1] Second Mil Med Univ, Dept Microbiol, Shanghai 200433, Peoples R China
[2] Second Mil Med Univ, Chagnzheng Hosp, Dept Infect Dis, Shanghai 200003, Peoples R China
关键词
viral receptor; hepatitis C virus; cell-based selection; hCD81-binding peptide; phage display; HEPATITIS-C VIRUS; E2; GLYCOPROTEIN; IDENTIFICATION; BINDING; LIBRARIES; ANTAGONISTS; ANTIBODIES; PROTEINS; MUSCLE; GENE;
D O I
10.1038/sj.cr.7290190
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The human CD81 (hCD81), the most recently proposed receptor of hepatitis C virus (HCV), can especifically bind to HCV envelope glycoprotein 2 (E2). In this study, hCD81 -expressing murine NIH/3T3 cells were used to select hCD81-binding peptides from a phage displayed nonapeptide library (PVIII9aaCys). Eighteen of the 75 clones selected from the library showed specific binding to the hCD81-expressing NIH/3T3 cells by enzyme linked immunosorbent assay (ELISA) and competitive inhibition test. Twelve out of the 18 clones shared the amino acid motif SPQYWTGPA. Sequence comparison of the motif showed no amino acid homology with the native HCV E2. The motif-containing phages could competitively inhibit the ability of HCV E2 binding to native hCD81-expressing MOLT-4 cells, and induce HCV E2 specific immune response in vivo. These results suggest that the selected motif SPQYWTGPA should be a mimotope of HCV E2 to bind to hCD81 molecules. Our findings cast new light on developing HCV receptor antagonists.
引用
收藏
页码:473 / 479
页数:7
相关论文
共 30 条
[11]   Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2 [J].
Higginbottom, A ;
Quinn, ER ;
Kuo, CC ;
Flint, M ;
Wilson, LH ;
Bianchi, E ;
Nicosia, A ;
Monk, PN ;
McKeating, JA ;
Levy, S .
JOURNAL OF VIROLOGY, 2000, 74 (08) :3642-3649
[12]   MOLECULAR-CLONING OF THE HUMAN HEPATITIS-C VIRUS GENOME FROM JAPANESE PATIENTS WITH NON-A, NON-B HEPATITIS [J].
KATO, N ;
HIJIKATA, M ;
OOTSUYAMA, Y ;
NAKAGAWA, M ;
OHKOSHI, S ;
SUGIMURA, T ;
SHIMOTOHNO, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :9524-9528
[13]  
KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205
[14]   CONSTRAINED PEPTIDES AS BINDING ENTITIES [J].
LADNER, RC .
TRENDS IN BIOTECHNOLOGY, 1995, 13 (10) :426-430
[15]   Bacteriophage display and discovery of peptide leads for drug development [J].
Lowman, HB .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1997, 26 :401-424
[16]   BY-PASSING IMMUNIZATION - HUMAN-ANTIBODIES FROM V-GENE LIBRARIES DISPLAYED ON PHAGE [J].
MARKS, JD ;
HOOGENBOOM, HR ;
BONNERT, TP ;
MCCAFFERTY, J ;
GRIFFITHS, AD ;
WINTER, G .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 222 (03) :581-597
[17]   IDENTIFICATION OF NOVEL PEPTIDE ANTAGONISTS FOR GPIIB/IIIA FROM A CONFORMATIONALLY CONSTRAINED PHAGE PEPTIDE LIBRARY [J].
ONEIL, KT ;
HOESS, RH ;
JACKSON, SA ;
RAMACHANDRAN, NS ;
MOUSA, SA ;
DEGRADO, WF .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1992, 14 (04) :509-515
[18]   TAPA-1, THE TARGET OF AN ANTIPROLIFERATIVE ANTIBODY, DEFINES A NEW FAMILY OF TRANSMEMBRANE PROTEINS [J].
OREN, R ;
TAKAHASHI, S ;
DOSS, C ;
LEVY, R ;
LEVY, S .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (08) :4007-4015
[19]   A sensitive immunoassay for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: abundant presence of fatty acid translocase CD36 in cardiac and red skeletal muscle and up-regulation in diabetes [J].
Pelsers, MMAL ;
Lutgerink, JT ;
van Nieuwenhoven, FA ;
Tandon, NN ;
van der Vusse, GJ ;
Arends, JW ;
Hoogenboom, HR ;
Glatz, JFC .
BIOCHEMICAL JOURNAL, 1999, 337 :407-414
[20]   Structure-function analysis of hepatitis C virus envelope-CD81 binding [J].
Petracca, R ;
Falugi, F ;
Galli, G ;
Norais, N ;
Rosa, D ;
Campagnoli, S ;
Burgio, V ;
Di Stasio, E ;
Giardina, B ;
Houghton, M ;
Abrignani, S ;
Grandi, G .
JOURNAL OF VIROLOGY, 2000, 74 (10) :4824-4830